Until now, the prognostic value of DmaxVox, a dissemination feature representing the metastatic spread of prostate cancer cells, has only been investigated in mCRPC patients receiving 177Lu-PSMA radioligand therapy [12]. The gene discussed is FOLH1; the disease is prostate carcinoma.